Occurrence of the free and Peptide forms of pyroglutamic acid in plasma from the portal blood of rats that had ingested a wheat gluten hydrolysate containing pyroglutamyl peptides.
In order to determine pyroglutamic acid levels in plasma, we developed a method based on precolumn derivatization of the carboxyl group of pyroglutamic acid with 2-nitrophenylhydrazine. Eight-week-old male SD strain rats were administered 200 mg of an acidic peptide fraction obtained from a commercial wheat gluten hydrolysate containing 0.63 mmol/g pyroglutamyl peptide. After administration, significant amounts of free pyroglutamic acid were observed in the ethanol-soluble fraction of the plasma from the portal vein. In addition, pyroglutamate aminopeptidase digestion of the ethanol-soluble fraction liberated significant amounts of pyroglutamic acid, which indicated the presence of the pyroglutamyl peptide. The presence of the pyroglutamyl peptide in the plasma was further confirmed by size exclusion chromatography. The levels of free and peptide forms of pyroglutamic acid increased significantly and reached a maximum (approximately 40 nmol/mL) at 15 and 30 min after administration, respectively.
Higaki-Sato
Noriko
N
Department of Food Sciences & Nutritional Health, Kyoto Prefectural University, 1-5 Shimogamo, Kyoto 606-8522, Japan.
Sato
Kenji
K
Inoue
Naomi
N
Nawa
Yuko
Y
Kido
Yasuhiro
Y
Nakabou
Yukihiro
Y
Hashimoto
Kaori
K
Nakamura
Yasushi
Y
Ohtsuki
Kozo
K
D000818:Animals; D002850:Chromatography, Gel; D005983:Glutens / Q000008:administration & dosage* / Q000737:chemistry*; D006868:Hydrolysis; D008297:Male; D010455:Peptides / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D011169:Portal Vein; D011751:Pyroglutamyl-Peptidase I / Q000378:metabolism; D011761:Pyrrolidonecarboxylic Acid / Q000008:administration & dosage* / Q000097:blood* / Q000737:chemistry; D051381:Rats; D014908:Triticum / Q000737:chemistry*
D010455:Peptides; D005983:Glutens; D011751:Pyroglutamyl-Peptidase I; D011761:Pyrrolidonecarboxylic Acid